GLDD Q4 2025 Earnings Strong Earnings Beat Amid Operational Improvements Prelude Therapeutics Q1 2026 Earnings Significant EPS Beat Amid No Revenue VIRC Q1 2026 Earnings Significant EPS Miss Amid Challenging Quarter AMPH Q1 2026 Earnings EPS Misses Estimates Stock Gains Ground VRE Q4 2025 Earnings EPS Surprises to the Upside Despite Loss Stock Virtually Flat URBN Q1 2026 Earnings EPS Surges Past Estimates as Stock Jumps 33